Education
About Us
Working with TipRanks
Follow Us
Hims & Hers Health (HIMS)
NYSE:HIMS
HIMS Stock Chart & Stats
$59.15
-$0.61(-2.20%)
At close: 4:00 PM EST
$59.15
-$0.61(-2.20%)
Day’s Range― - ―
52-Week Range$18.33 - $72.98
Previous CloseN/A
Volume4.28M
Average Volume (3M)29.81M
Market Cap
$13.37B
Enterprise Value$12.70B
Total Cash (Recent Filing)$1.14B
Total Debt (Recent Filing)$1.04B
Price to Earnings (P/E)74.0
Beta2.57
Next Earnings
Nov 03, 2025EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.17
Shares Outstanding217,641,950
10 Day Avg. Volume30,559,120
30 Day Avg. Volume29,806,196
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.95
Enterprise Value/Revenue6.31
Enterprise Value/Gross Profit8.28
Enterprise Value/Ebitda82.06
Forecast
1Y Price Target
$50.11Price Target Upside-15.28% Downside
Rating ConsensusHold
Number of Analyst Covering12
Bulls Say, Bears Say
Bulls Say
Product OfferingsThe official launch of the menopause and perimenopause offering is viewed as an incremental positive, helping to expand the total addressable market for HIMS and enhancing the Hers brand in a category with growing demand.
Revenue DiversificationThe Hers revenue stream and brand was bolstered by the weight loss category, which saw meaningful traction with women, helping mitigate recent pressure on the Hims business by diversifying the revenue stream.
Revenue GrowthThe company's entry into menopause and perimenopause treatments is expected to help the Hers brand surpass $1 billion in annual revenue next year.
Bears Say
CompetitionThe company's entry into this market follows multiple competitor offerings, indicating increased competition.
Regulatory ChallengesNew direct-to-consumer advertising regulations could pressure ad conversion across segments.
Sales GrowthRising competition and churn in sexual health have caused core sales growth to stall.
Hims & Hers Health News
HIMS FAQ
What was Hims & Hers Health’s price range in the past 12 months?
Hims & Hers Health lowest stock price was $18.32 and its highest was $72.98 in the past 12 months.
What is Hims & Hers Health’s market cap?
Hims & Hers Health’s market cap is $13.37B.
When is Hims & Hers Health’s upcoming earnings report date?
Hims & Hers Health’s upcoming earnings report date is Nov 03, 2025 which is in 16 days.
How were Hims & Hers Health’s earnings last quarter?
Hims & Hers Health released its earnings results on Aug 04, 2025. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.151 by $0.019.
Is Hims & Hers Health overvalued?
According to Wall Street analysts Hims & Hers Health’s price is currently Overvalued.
Does Hims & Hers Health pay dividends?
Hims & Hers Health does not currently pay dividends.
What is Hims & Hers Health’s EPS estimate?
Hims & Hers Health’s EPS estimate is 0.1.
How many shares outstanding does Hims & Hers Health have?
Hims & Hers Health has 217,641,950 shares outstanding.
What happened to Hims & Hers Health’s price movement after its last earnings report?
Hims & Hers Health reported an EPS of $0.17 in its last earnings report, beating expectations of $0.151. Following the earnings report the stock price went down -12.36%.
Which hedge fund is a major shareholder of Hims & Hers Health?
Currently, no hedge funds are holding shares in HIMS
Hims & Hers Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$50.11 (-15.28% Downside)
$50.11 (-15.28% Downside)
Blogger Sentiment
Bullish
HIMS Sentiment 84%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 101.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $37.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days <0.1%
Last 30 Days ▼ 2.2%
Last 30 Days ▼ 2.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
164.53%
12-Months-Change
Fundamentals
Return on Equity
41.88%
Trailing 12-Months
Asset Growth
290.76%
Trailing 12-Months
Company Description
Hims & Hers Health
Hims & Hers Health (HIMS) is a telehealth company focused on providing accessible healthcare solutions primarily for men and women. Founded in 2017, the company operates in the digital health sector, offering a range of products and services including prescription medications for conditions such as erectile dysfunction, hair loss, and skincare, as well as wellness products like vitamins and supplements. HIMS leverages a direct-to-consumer model, utilizing an online platform that allows customers to consult with licensed healthcare professionals and receive treatment through a convenient digital experience.
HIMS Company Deck
HIMS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlights strong revenue growth, international expansion, and technological advancements, signaling a positive outlook for the company's future. However, challenges such as the decline in GLP-1 subscribers and increased costs present hurdles. The balance of positive growth metrics against operational challenges results in a mixed sentiment.View all HIMS earnings summariesHIMS Revenue Breakdown
96.60% Online
3.40% Wholesale
HIMS Stock 12 Month Forecast
Average Price Target
$50.11
▼(-15.28% Downside)
Technical Analysis
Ownership Overview
0.98% Insiders
19.96% Mutual Funds
0.28% Other Institutional Investors
56.57% Public Companies and Individual Investors